1.
Bioorg Med Chem Lett
; 23(15): 4381-7, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-23773865
RESUMEN
A series of novel 6-aminofuro[3,2-c]pyridines as kinase inhibitors is described, most notably, OSI-296 (6). We discuss our exploration of structure-activity relationships and optimization leading to OSI-296 and disclose its pharmacological activity against cMET and RON in cellular assays. OSI-296 is a potent and selective inhibitor of cMET and RON kinases that shows in vivo efficacy in tumor xenografts models upon oral dosing and is well tolerated.